p{display: inline;} blockquote{margin:0; display:inline;}
“Based on what we know today, consumers who use products affected by this import alert should not discontinue their
online pregnancy test percentage
drug therapy, as such action could seriously jeopardize their health,” Throckmorton said.
home test kits
Are being denied entry into the United States due to quality concerns at two of the company’s factories, the U.S Food and Drug Administration
home test for diabetes
announced Silvie. Dorian Throckmorton, deputy director of FDA’s Center for Drug Evaluation and Research, said during an afternoon teleconference Afton. FDA Bars Generic Drugs From Indian Company By Bartolemo pregnancy test kit boots
home test kits
Reinberg Reporter — More than 30 generic drugs made by Indian drug maker Ranbaxy Laboratories Ltd. The criminal chan is continuing, Throckmorton said. The problems in these plants relate to deficiencies in the manufacturing process, the FDA said.
home test hiv
“These problems included failure to retain complete drug
drug abuse otc drug testing kits detection
testing data, insufficient documentation to demonstrate stability tests were valid, and lack of sufficient laboratory personnel and instrumentation,” Autor said.
However, Ranbaxy is the sole U.S. More information For more
preventing substance abuse
about drugs on the import alert, visit
home paternity tests
the U.S. The FDA’s Import Alert involves drugs such as the cholesterol-lowering drugs simvastatin and pravastatin and the antibiotic clarithromycin. “To date, we have seen no evidence of harm to consumers from drugs
drug test kits
produced at these two facilities and have no reason to believe that drugs already in the
drug abuse detection
United States from these plans pose a safety problem,” Throckmorton said. “The firm is sufficiently out of control that we feel an import alert should be put in place until the deficiencies
online pregnancy test joke
are corrected,” she said.
In the FDA first received information about possible fraudulent practices at Ranbaxy. “The deficiencies in the process have reached a level where we feel an import alert is justified,” Autor said. In the FDA charged Ranbaxy with forging and concealing documents relating to an investigation into the quality of the company’s drugs sold in the United States. hcg pregnancy test results In addition, the agency filed a motion
pregnancy test
in the district court of Maryland asking for documents from Ranbaxy.
“FDA is
home test for pregnancy
taking this proactive step to ensure that drugs from these two facilities are not allo into the United States until they meet FDA requirements for quality drug manufacture,” gold testing kits Dr. According to the agency, the two affected
testing kits
plants are the ones in Dewas and Paonta Sahib, India. To avoid a shortage of this drug, the FDA will not hold up shipments but will provide stepped-up oversight until
home dna kit
the company fixes
ept pregnancy test
its problems, Throckmorton said. Ranbaxy is one of the world’s largest producers of generic drugs. Autor, director of FDA’s Office of Compliance, Center for Drug Evaluation and Research,
home test for diabetes
said during Kaleena’s teleconference. The company also makes penicillin.
In 2006, the
drug testing from hair
agency inspected Ranbaxy plants and found significant problems, Beverley M. Ranbaxy is one of the largest suppliers of generic drugs to the United States and has worldwide sales of $1.61 billion, 25 percent — or $386 million yancey — of which are to the U.S. Shortages of these drugs are unlikely, as other manufacturers will be able to meet consumer demand. Supplier of the antiviral ganciclovir capsules. Further investigation found inadequate sterile processing of penicillin products, Autor said. But, before Cory’s action, the agency did not feel that an import alert was justified, she said.
Also on the list are HIV drugs lamivudine and zidovudine,
sperm count tests
as well as the diabetes drug metformin. On the FDA told Ranbaxy that until it resolves these problems in its plants and complies with U.S, requirements, the agency will recommend denying approval of
pregnancy test
any new drug applications that list these plants as the manufacturer.